{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:16:12Z","timestamp":1790093772868,"version":"4.0.1"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Nuclear imaging techniques can detect and quantify pathophysiological processes underlying heart failure, complementing evaluation of cardiac structure and function with other imaging modalities. Combined imaging of myocardial perfusion and metabolism can identify left ventricle dysfunction caused by myocardial ischaemia that may be reversible after revascularization in the presence of viable myocardium. High sensitivity of nuclear imaging to detect targeted tracers has enabled assessment of various cellular and subcellular mechanisms of heart failure. Nuclear imaging of active inflammation and amyloid deposition is incorporated into clinical management algorithms of cardiac sarcoidosis and amyloidosis. Innervation imaging has well-documented prognostic value with respect to heart failure progression and arrhythmias. Emerging tracers specific for inflammation and myocardial fibrotic activity are in earlier stages of development but have demonstrated potential value in early characterization of the response to myocardial injury and prediction of adverse left ventricular remodelling. Early detection of disease activity is a key for transition from broad medical treatment of clinically overt heart failure towards a personalized approach aimed at supporting repair and preventing progressive failure. This review outlines the current status of nuclear imaging in phenotyping heart failure and combines it with discussion on novel developments.<\/jats:p>","DOI":"10.1093\/ehjci\/jead128","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T21:13:25Z","timestamp":1686258805000},"page":"1318-1328","source":"Crossref","is-referenced-by-count":16,"title":["Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-0893","authenticated-orcid":false,"given":"Antti","family":"Saraste","sequence":"first","affiliation":[{"name":"Turku PET Centre, Turku University Hospital and University of Turku , Kiinamyllynkatu 4\u20138, 20520 Turku , Finland"},{"name":"Heart Center, Turku University Hospital and University of Turku , H\u00e4meentie 11, 20520 Turku , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-9593","authenticated-orcid":false,"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku University Hospital and University of Turku , Kiinamyllynkatu 4\u20138, 20520 Turku , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bengel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hannover Medical School , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"2023102011135232500_jead128-B1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2967\/jnumed.119.240440","article-title":"The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine","volume":"61","author":"Werner","year":"2020","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2967\/jnumed.121.263507","article-title":"Radiotracers to address unmet clinical needs in cardiovascular imaging, Part 1: Technical considerations and perfusion and neuronal imaging","volume":"63","author":"Stendahl","year":"2022","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2967\/jnumed.121.263507","article-title":"Radiotracers to address unmet clinical needs in cardiovascular imaging, Part 2: inflammation, fibrosis, thrombosis, calcification, and amyloidosis imaging","volume":"63","author":"Stendahl","year":"2022","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology","volume":"18","author":"Slart","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B6","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","article-title":"SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0","volume":"54","author":"Dorbala","year":"2013","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurheartj\/ehac640","article-title":"Use of cardiac imaging in chronic coronary syndromes: the EURECA imaging registry","volume":"44","author":"Neglia","year":"2023","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B10","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s00259-016-3467-5","article-title":"Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)","volume":"43","author":"Agostini","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41824-019-0058-2","article-title":"EANM Procedural guidelines for myocardial perfusion scintigraphy using cardiac-centered gamma cameras","volume":"3","author":"Hyafil","year":"2019","journal-title":"Eur J Hybrid Imaging"},{"key":"2023102011135232500_jead128-B12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2967\/jnumed.114.139782","article-title":"Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model","volume":"55","author":"Wells","year":"2014","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00259-018-3958-7","article-title":"First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study","volume":"45","author":"Agostini","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B14","first-page":"436","article-title":"Simultaneous dual-isotope solid state detector SPECT for improved tracking of white blood cells in suspected endocarditis","volume":"38","author":"Caobelli","year":"2017","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2009.02.065","article-title":"Cardiac positron emission tomography","volume":"54","author":"Bengel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00259-020-05046-9","article-title":"EANM Procedural guidelines for PET\/CT quantitative myocardial perfusion imaging","volume":"48","author":"Sciagr\u00e0","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jcmg.2019.08.030","article-title":"Myocardial efficiency: a fundamental physiological concept on the verge of clinical impact","volume":"13","author":"S\u00f6rensen","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.119.226498","article-title":"First human imaging studies with the EXPLORER total-body PET scanner","volume":"60","author":"Badawi","year":"2019","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B19","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1007\/s00259-021-05461-6","article-title":"Long axial field of view PET scanners: a road map to implementation and new possibilities","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11886-017-0825-2","article-title":"Enhancing cardiac PET by motion correction techniques","volume":"19","author":"Rubeaux","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"2023102011135232500_jead128-B21","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jcmg.2022.05.008","article-title":"Parametric imaging of biologic activity of atherosclerosis using dynamic whole-body positron emission tomography","volume":"15","author":"Derlin","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2967\/jnumed.111.092528","article-title":"Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest","volume":"52","author":"Maddahi","year":"2011","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B23","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2967\/jnumed.114.140137","article-title":"Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation","volume":"55","author":"Sinusas","year":"2014","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B24","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/ehjci\/jeab053","article-title":"Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI)","volume":"22","author":"Almeida","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ehjci\/jez219","article-title":"Imaging in ESC clinical guidelines: chronic coronary syndromes","volume":"20","author":"Saraste","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2020.05.063","article-title":"Phase-III clinical trial of fluorine-18 flurpiridaz positron emission tomography for evaluation of coronary artery disease","volume":"76","author":"Maddahi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ehjci\/jeab267","article-title":"18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization","volume":"23","author":"Packard","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B28","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1093\/eurheartj\/ehy267","article-title":"The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability","volume":"39","author":"Knuuti","year":"2018","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B29","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/eurheartj\/ehac286","article-title":"Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study","volume":"43","author":"Driessen","year":"2022","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B30","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2012.07.038","article-title":"Does rubidium-82 pet have superior accuracy to spect perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis","volume":"60","author":"Mc Ardle","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2012.09.043","article-title":"Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry","volume":"61","author":"Dorbala","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B32","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.117.029992","article-title":"Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease","volume":"136","author":"Gupta","year":"2017","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/hc0202.102119","article-title":"Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction","volume":"105","author":"Neglia","year":"2002","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ehjci\/jev012","article-title":"Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes","volume":"16","author":"Majmudar","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"2023102011135232500_jead128-B36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2023102011135232500_jead128-B37","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of takotsubo syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B38","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcmg.2020.05.033","article-title":"Prognostic value of quantitative metrics from positron emission tomography in ischemic heart failure","volume":"14","author":"Benz","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B41","doi-asserted-by":"crossref","first-page":"e012426","DOI":"10.1161\/CIRCIMAGING.121.012426","article-title":"Relative prognostic significance of positron emission tomography myocardial perfusion imaging markers in cardiomyopathy","volume":"14","author":"Thomas","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","article-title":"Hibernating myocardium: diagnosis and patient outcomes","volume":"32","author":"Schinkel","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"2023102011135232500_jead128-B43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.112.000138","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B45","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B46","doi-asserted-by":"crossref","first-page":"e004331","DOI":"10.1161\/CIRCIMAGING.115.004331","article-title":"Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Ardle","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B47","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"2023102011135232500_jead128-B48","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2023102011135232500_jead128-B49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","article-title":"The Heart Failure Revascularisation Trial (HEART)","volume":"13","author":"Cleland","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2023102011135232500_jead128-B50","doi-asserted-by":"crossref","first-page":"e026943","DOI":"10.1161\/JAHA.122.026943","article-title":"Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how","volume":"12","author":"Liga","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2023102011135232500_jead128-B51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B52","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B54","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B56","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"18F-fluorodeoxyglucose Positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"key":"2023102011135232500_jead128-B57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic accuracy of cardiac MRI versus FDG PET for cardiac sarcoidosis: a systematic review and meta-analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"key":"2023102011135232500_jead128-B58","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B59","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1097\/RLU.0000000000001063","article-title":"Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"41","author":"Tang","year":"2016","journal-title":"Clin Nucl Med"},{"key":"2023102011135232500_jead128-B60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"2023102011135232500_jead128-B61","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"2023102011135232500_jead128-B62","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2967\/jnumed.116.174045","article-title":"11C-Methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis","volume":"57","author":"Maya","year":"2016","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B63","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging cardiac sarcoidosis with FLT-PET compared with FDG\/perfusion-PET: a prospective pilot study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"2023102011135232500_jead128-B65","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2967\/jnumed.119.241356","article-title":"Folate receptor \u03b2-targeted PET imaging of macrophages in autoimmune myocarditis","volume":"61","author":"Jahandideh","year":"2020","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B66","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B67","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B68","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023102011135232500_jead128-B69","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B70","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","author":"Azevedo Coutinho","year":"2020","journal-title":"Amyloid"},{"key":"2023102011135232500_jead128-B71","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B72","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD Quantification in cardiac amyloidosis: a novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B73","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2967\/jnumed.120.247312","article-title":"Absolute quantitation of cardiac 99mTc-pyrophosphate using cadmium zinc telluride-based SPECT\/CT","volume":"62","author":"Dorbala","year":"2021","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18Fflorbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"(11)C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B76","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B77","doi-asserted-by":"crossref","first-page":"e002954","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir Binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B78","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B79","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early detection of multiorgan light chain amyloidosis by whole-body 18F-florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2019.11.037","article-title":"Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis","volume":"75","author":"Lee","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B81","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2967\/jnumed.121.263033","article-title":"Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis","volume":"63","author":"Choi","year":"2022","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B82","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/ehjci\/jeab007","article-title":"The role of myocardial innervation imaging in different clinical scenarios: an expert document of the European Association of Cardiovascular Imaging and Cardiovascular Committee of the European Association of Nuclear Medicine","volume":"22","author":"Gimelli","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B83","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","article-title":"Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review","volume":"29","author":"Verberne","year":"2008","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B84","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B85","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.115.156406","article-title":"\u00b9\u00b2\u00b3I-MIBG imaging for prediction of mortality and potentially fatal events in heart failure: the ADMIRE-HFX study","volume":"56","author":"Narula","year":"2015","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B86","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.jacc.2008.02.062","article-title":"Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction","volume":"51","author":"Sasano","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B87","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00259-016-3461-y","article-title":"Relationships between cardiac innervation\/perfusion imbalance and ventricular arrhythmias: impact on invasive electrophysiological parameters and ablation procedures","volume":"43","author":"Gimelli","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B89","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.120.315899","article-title":"Metabolic and molecular imaging of the diabetic cardiomyopathy","volume":"126","author":"Peterson","year":"2020","journal-title":"Circ Res"},{"key":"2023102011135232500_jead128-B90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cvr\/cvr052","article-title":"Metabolic remodelling in human heart failure","volume":"90","author":"Tuunanen","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2023102011135232500_jead128-B91","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s12350-018-1338-0","article-title":"Automatic calculation of myocardial external efficiency using a single 11C-acetate PET scan","volume":"25","author":"Harms","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023102011135232500_jead128-B92","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12350-018-1302-z","article-title":"Test-retest repeatability of myocardial oxidative metabolism and efficiency using standalone dynamic 11C-acetate PET and multimodality approaches in healthy controls","volume":"25","author":"Hansson","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2023102011135232500_jead128-B93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002590050040","article-title":"Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate\u2013comparison between the normal and failing human heart","volume":"27","author":"Bengel","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"2023102011135232500_jead128-B94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cardfail.2003.08.009","article-title":"Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy","volume":"10","author":"Stolen","year":"2004","journal-title":"J Card Fail"},{"key":"2023102011135232500_jead128-B95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ehjci\/jeab227","article-title":"Myocardial efficiency in patients with different aetiologies and stages of heart failure","volume":"23","author":"Hansen","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B96","doi-asserted-by":"crossref","first-page":"e005604","DOI":"10.1161\/CIRCIMAGING.116.005604","article-title":"Disease stage-dependent changes in cardiac contractile performance and oxygen utilization underlie reduced myocardial efficiency in human inherited hypertrophic cardiomyopathy","volume":"10","author":"G\u00fc\u00e7l\u00fc","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B97","doi-asserted-by":"crossref","first-page":"e009974","DOI":"10.1161\/JAHA.118.009974","article-title":"Myocardial oxygen consumption and efficiency in patients with cardiac amyloidosis","volume":"7","author":"Clemmensen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023102011135232500_jead128-B98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00259-001-0694-0","article-title":"Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart","volume":"29","author":"Bengel","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023102011135232500_jead128-B99","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0735-1097(02)01775-8","article-title":"Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm","volume":"39","author":"Kim","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B100","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.106.645184","article-title":"Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure","volume":"114","author":"Tuunanen","year":"2006","journal-title":"Circulation"},{"key":"2023102011135232500_jead128-B101","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B102","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023102011135232500_jead128-B103","doi-asserted-by":"crossref","first-page":"e004316","DOI":"10.1161\/CIRCIMAGING.115.004316","article-title":"Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography\/magnetic resonance imaging as a prognostic marker of functional outcome","volume":"9","author":"Rischpler","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B104","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur Heart J"},{"key":"2023102011135232500_jead128-B105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jcmg.2021.08.013","article-title":"CXCR4-targeted Imaging of post-infarct myocardial tissue inflammation: prognostic value after reperfused myocardial infarction","volume":"15","author":"Werner","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B106","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","article-title":"Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart","volume":"124","author":"Heo","year":"2019","journal-title":"Circ Res"},{"key":"2023102011135232500_jead128-B107","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","article-title":"68Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction","volume":"73","author":"Tarkin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B109","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","article-title":"Imaging systemic inflammatory networks in ischemic heart disease","volume":"65","author":"Nahrendorf","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/heartjnl-2016-310115","article-title":"Cardiac \u03b1V\u03b23 integrin expression following acute myocardial infarction in humans","volume":"103","author":"Jenkins","year":"2017","journal-title":"Heart"},{"key":"2023102011135232500_jead128-B111","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12967-017-1245-1","article-title":"Imaging of \u03b1v\u03b23 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography","volume":"15","author":"Gr\u00f6nman","year":"2017","journal-title":"J Transl Med"},{"key":"2023102011135232500_jead128-B112","doi-asserted-by":"crossref","first-page":"e009055","DOI":"10.1161\/CIRCIMAGING.119.009055","article-title":"Application of hybrid matrix metalloproteinase-targeted and dynamic (201)Tl single-photon emission computed tomography\/computed tomography imaging for evaluation of early post-myocardial infarction remodeling","volume":"12","author":"Thorn","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102011135232500_jead128-B113","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.jacc.2012.09.023","article-title":"Molecular hybrid positron emission tomography\/computed tomography imaging of cardiac angiotensin II type 1 receptors","volume":"60","author":"Fukushima","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B114","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction","volume":"77","author":"Diekmann","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023102011135232500_jead128-B115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"key":"2023102011135232500_jead128-B116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/CIRCRESAHA.120.318539","article-title":"Molecular imaging of inflammation and fibrosis in pressure overload heart failure","volume":"129","author":"Glasenapp","year":"2021","journal-title":"Circ Res"},{"key":"2023102011135232500_jead128-B117","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"2023102011135232500_jead128-B118","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"2023102011135232500_jead128-B119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jead128\/50561251\/jead128.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/24\/10\/1318\/51769997\/jead128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/24\/10\/1318\/51769997\/jead128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:17:32Z","timestamp":1697800652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/24\/10\/1318\/7192817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":119,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,6,9]]},"published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jead128","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,6,9]]}}}